RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade

Biological Chemistry

Volumn 389, Issue 10, 2008, Pages 1273-1282

  Pleschka, Stephan ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Extracellular signal regulated kinase; Virus replication

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAF PROTEIN;

APOPTOSIS; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CORONAVIRUS; DNA VIRUS; EBOLA VIRUS; FILOVIRIDAE; FLAVIVIRUS; GENE EXPRESSION; HEPATITIS C; INFLUENZA VIRUS; NONHUMAN; ORTHOMYXOVIRUS; PICORNAVIRUS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RNA VIRUS; SARS CORONAVIRUS; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE KINASE KINASES; RAF KINASES; RNA VIRUS INFECTIONS; RNA VIRUSES; SIGNAL TRANSDUCTION;

CORONAVIRUS; DNA VIRUSES; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 54049131196     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2008.145     Document Type: Review

References (95)

1. + T lymphocytes. J. Immunol. 173, 7150-7160.
2. Barber, S.A., Bruett, L., Douglass, B.R., Herbst, D.S., Zink, M.C., and Clements, J.E. (2002). Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J. Virol. 76, 817-828.
3. Battcock, S.M., Collier, T.W., Zu, D., and Hirasawa, K. (2006). Negative regulation of the α interferon-induced antiviral response by the Ras/Raf/MEK pathway. J. Virol. 80, 4422-4430.
4. Bode, J.G., Brenndörfer, E.D., and Häussinger, D. (2008). HCV employs multiple strategies to subvert innate antiviral response. Biol. Chem. 389, 1283-1298.
5. Briant, L., Robert-Hebmann, V., Sivan, V., Brunet, A., Pouyssegur, J., and Devaux, C. (1998). Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-κ B and AP-1 transcription factors. J. Immunol. 160, 1875-1885.
6. Cai, Y., Liu, Y., and Zhang, X. (2006). Induction of transcription factor Egr-1 gene expression in astrocytoma cells by murine coronavirus infection. Virology 355, 152-163.
7. Cai, Y., Liu, Y., and Zhang, X. (2007). Suppression of coronavirus replication by inhibition of the MEK signaling pathway. J. Virol. 81, 446-456.
8. Cartier, C., Deckert, M., Grangeasse, C., Trauger, R., Jensen, F., Bernard, A., Cozzone, A., Desgranges, C., and Boyer, V. (1997). Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles. J. Virol. 71, 4832-4837.
9. Chen, C.J., Chen, J.H., Chen, S.Y., Liao, S.L., and Raung, S.L. (2004). Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J. Virol. 78, 12107-12119.
10. Chen, W., Monick, M.M., Carter, A.B., and Hunninghake, G.W. (2000). Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8. Exp. Lung Res. 26, 13-26.
11. Cohen, P. (2002). Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1, 309-315.
12. Cunningham, K.A., Chapman, N.M., and Carson, S.D. (2003). Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants. Virus Res. 92, 179-186.
13. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G., and Tsichlis, P.N. (2000). TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERKdependent pathway. Cell 103, 1071-1083.
14. Eisenberg, S., Shvartsman, D.E., Ehrlich, M., and Henis, Y.I. (2006). Clustering of raft-associated proteins in the external membrane leaflet modulates internal leaflet H-ras diffusion and signaling. Mol. Cell. Biol. 26, 7190-7200.
15. Erhardt, A., Hassan, M., Heintges, T., and Häussinger, D. (2002). Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 292, 272-284.
16. Fiala, M., Popik, W., Qiao, J.H., Lossinsky, A.S., Alce, T., Tran, K., Yang, W., Roos, K.P., and Arthos, J. (2004). HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling. Cardiovasc. Toxicol. 4, 97-107.
17. Flory, E., Weber, C.K., Chen, P., Hoffmeyer, A., Jassoy, C., and Rapp, U.R. (1998). Plasma membrane-targeted Raf kinase activates NF-κB and human immunodeficiency virus type 1 replication in T lymphocytes. J. Virol. 72, 2788-2794.
18. Friday, B.B. and Adjei, A.A. (2008). Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin. Cancer Res. 14, 342-346.
19. Fukuda, K., Tsuchihara, K., Hijikata, M., Nishiguchi, S., Kuroki, T., and Shimotohno, K. (2001). Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli. Hepatology 33, 159-165.
20. Funk, C.D. and FitzGerald, G.A. (2007). COX-2 inhibitors and cardiovascular risk. J. Cardiovasc. Pharmacol. 50, 470-479.
21. Gee, K., Angel, J.B., Ma, W., Mishra, S., Gajanayaka, N., Parato, K., and Kumar, A. (2006). Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. J. Biol. Chem. 281, 31647-31658.
22. Georgopoulou, U., Tsitoura, P., Kalamvoki, M., and Mavromara, P. (2006). The protein phosphatase 2A represents a novel cellular target for hepatitis C virus NS5A protein. Biochimie 88, 651-662.
23. Giambartolomei, S., Covone, F., Levrero, M., and Balsano, C. (2001). Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. Oncogene 20, 2606-2610.
24. Gibellini, D., Re, M.C., Bassini, A., Guidotti, L., Catani, L., La Placa, M., and Zauli, G. (1999). HIV-1 gp120 induces the activation of both c-fos and c-jun immediate-early genes in HEL megakaryocytic cells. Br. J. Haematol. 104, 81-86.
25. Haller, C. and Fackler, O. (2008). HIV-1 at the immunological and T-lymphocytic virological synapse. Biol. Chem. 389, 1253-1260.
26. Han, Z. and Harty, R.N. (2007). Influence of calcium/calmodulin on budding of Ebola VLPs: implications for the involvement of the Ras/Raf/MEK/ERK pathway. Virus Genes 35, 511-520.
27. Hans, A., Bajramovic, J.J., Syan, S., Perret, E., Dunia, I., Brahic, M., and Gonzalez-Dunia, D. (2004). Persistent, noncytolytic infection of neurons by Borna disease virus interferes with ERK 1/2 signaling and abrogates BDNF-induced synaptogenesis. FASEB J. 18, 863-865.
28. Hayashi, J., Aoki, H., Kajino, K., Moriyama, M., Arakawa, Y., and Hino, O. (2000). Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor α. Hepatology 32, 958-961.
29. Hemonnot, B., Cartier, C., Gay, B., Rebuffat, S., Bardy, M., Devaux, C., Boyer, V., and Briant, L. (2004). The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1. J. Biol. Chem. 279, 32426-32434.
30. Huber, M., Watson, K.A., Selinka, H.C., Carthy, C.M., Klingel, K., McManus, B.M., and Kandolf, R. (1999). Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J. Virol. 73, 3587-3594.
31. + T lymphocytes. Eur. J. Immunol. 27, 397-404.
32. Jacque, J.M., Mann, A., Enslen, H., Sharova, N., Brichacek, B., Davis, R.J., and Stevenson, M. (1998). Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17, 2607-2618.
33. Klumpp, K. (2004). Recent advances in the discovery and development of anti-influenza drugs. Expert Opin. Ther. Patents 14, 1153-1168.
34. Kong, X., San Juan, H., Behera, A., Peeples, M.E., Wu, J., Lockey, R.F., and Mohapatra, S.S. (2004). ERK-1/2 activity is required for efficient RSV infection. FEBS Lett. 559, 33-38.
35. Lannuzel, A., Barnier, J.V., Hery, C., Huynh, V.T., Guibert, B., Gray, F., Vincent, J.D., and Tardieu, M. (1997). Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann. Neurol. 42, 847-856.
36. Lim, B.K., Nam, J.H., Gil, C.O., Yun, S.H., Choi, J.H., Kim, D.K., and Jeon, E.S. (2005). Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal. Virus Res. 113, 153-157.
37. Liu, M., Yang, Y., Gu, C., Yue, Y., Wu, K.K., Wu, J., and Zhu, Y. (2007). Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways. FASEB J. 21, 1586-1596.
38. Ludwig, S. and Planz, O. (2008). Influenza viruses and the NFκB signaling pathway-towards a novel concept of antiviral therapy. Biol. Chem. 389, 1307-1312.
39. Ludwig, S., Planz, O., Pleschka, S., and Wolff, T. (2003). Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol. Med. 9, 46-52.
40. Ludwig, S., Wolff, T., Ehrhardt, C., Wurzer, W.J., Reinhardt, J., Planz, O., and Pleschka, S. (2004). MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett. 561, 37-43.
41. Ludwig, S., Pleschka, S., Planz, O., and Wolff, T. (2006). Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell. Microbiol. 8, 375-386.
42. Luo, H., Yanagawa, B., Zhang, J., Luo, Z., Zhang, M., Esfandiarei, M., Carthy, C., Wilson, J.E., Yang, D., and McManus, B.M. (2002). Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J. Virol. 76, 3365-3373.
43. Macdonald, A., Crowder, K., Street, A., McCormick, C., Saksela, K., and Harris, M. (2003). The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J. Biol. Chem. 278, 17775-17784.
44. Marjuki, H., Alam, M.I., Ehrhardt, C., Wagner, R., Planz, O., Klenk, H.D., Ludwig, S., and Pleschka, S. (2006). Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Cα-mediated activation of ERK signaling. J. Biol. Chem. 281, 16707-16715.
45. Marjuki, H., Yen, H.L., Franks, J., Webster, R.G., Pleschka, S., and Hoffmann, E. (2007). Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. Virol. J. 4, 134.
46. Marozsan, A.J., Torre, V.S., Johnson, M., Ball, S.C., Cross, J.V., Templeton, D.J., Quinones-Mateu, M.E., Offord, R.E., and Arts, E.J. (2001). Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES. J. Virol. 75, 8624-8638.
47. Marquez, N., Calzado, M.A., Sanchez-Duffhues, G., Perez, M., Minassi, A., Pagani, A., Appendino, G., Diaz, L., Munoz-Fernandez, M.A., and Munoz, E. (2008). Differential effects of phorbol-13-monoesters on human immunodeficiency virus reactivation. Biochem. Pharmacol. 75, 1370-1380.
48. Martinez, O., Valmas, C., and Basler, C.F. (2007). Ebola virus-like particle-induced activation of NF-κB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain. Virology 364, 342-354.
49. Mazzocca, A., Sciammetta, S.C., Carloni, V., Cosmi, L., Annunziato, F., Harada, T., Abrignani, S., and Pinzani, M. (2005). Binding of hepatitis C virus envelope protein E2 to CD81 upregulates matrix metalloproteinase-2 in human hepatic stellate cells. J. Biol. Chem. 280, 11329-11339.
50. Mischiati, C., Pironi, F., Milani, D., Giacca, M., Mirandola, P., Capitani, S., and Zauli, G. (1999). Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. Aids 13, 1637-1645.
51. Mizumura, K., Hashimoto, S., Maruoka, S., Gon, Y., Kitamura, N., Matsumoto, K., Hayashi, S., Shimizu, K., and Horie, T. (2003). Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells. Clin. Exp. Allergy 33, 1244-1251.
52. Monick, M., Staber, J., Thomas, K., and Hunninghake, G. (2001). Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase. J. Immunol. 166, 2681-2687.
53. Murata, T., Hijikata, M., and Shimotohno, K. (2005). Enhancement of internal ribosome entry site-mediated translation and replication of hepatitis C virus by PD98059. Virology 340, 105-115.
54. Noah, D.L., Twu, K.Y., and Krug, R.M. (2003). Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307, 386-395.
55. Noser, J.A., Mael, A.A., Sakuma, R., Ohmine, S., Marcato, P., Lee, P.W., and Ikeda, Y. (2007). The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells. Mol. Ther. 15, 1531-1536.
56. Olschlager, V., Pleschka, S., Fischer, T., Rziha, H.J., Wurzer, W., Stitz, L., Rapp, U.R., Ludwig, S., and Planz, O. (2004). Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 23, 6639-6646.
57. Opavsky, M.A., Martino, T., Rabinovitch, M., Penninger, J., Richardson, C., Petric, M., Trinidad, C., Butcher, L., Chan, J., and Liu, P.P. (2002). Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J. Clin. Invest. 109, 1561-1569.
58. Osiecki, K., Xie, L., Zheng, J.H., Squires, R., Pettoello-Mantovani, M., and Goldstein, H. (2005). Identification of granulocyte-macrophage colony-stimulating factor and lipopolysaccharide-induced signal transduction pathways that synergize to stimulate HIV type 1 production by monocytes from HIV type 1 transgenic mice. AIDS Res. Hum. Retroviruses 21, 125-139.
59. Pang, R.W. and Poon, R.T. (2007). From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 72 (Suppl. 1), 30-44.
60. Pazdrak, K., Olszewska-Pazdrak, B., Liu, T., Takizawa, R., Brasier, A.R., Garofalo, R.P., and Casola, A. (2002). MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L364-372.
61. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.E., Karandikar, M., Berman, K., and Cobb, M.H. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183.
62. Planz, O., Pleschka, S., and Ludwig, S. (2001a). MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75, 4871-4877.
63. Planz, O., Pleschka, S., and Ludwig, S. (2001b). MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75, 4871-4877.
64. Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., Planz, O., Rapp, U.R., and Ludwig, S. (2001). Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3, 301-305.
65. Popik, W., Hesselgesser, J.E., and Pitha, P.M. (1998). Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J. Virol. 72, 6406-6413.
66. Raung, S.L., Chen, S.Y., Liao, S.L., Chen, J.H., and Chen, C.J. (2007). Japanese encephalitis virus infection stimulates Src tyrosine kinase in neuron/glia. Neurosci. Lett. 419, 263-268.
67. Roberts, P.J. and Der, C.J. (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291-3310.
68. Rusnati, M., Urbinati, C., Musulin, B., Ribatti, D., Albini, A., Noonan, D., Marchisone, C., Waltenberger, J., and Presta, M. (2001). Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein. Endothelium 8, 65-74.
69. Sarkar, S.N., Peters, K.L., Elco, C.P., Sakamoto, S., Pal, S., and Sen, G.C. (2004). Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 11, 1060-1067.
70. Sato, Y., Kato, J., Takimoto, R., Takada, K., Kawano, Y., Miyanishi, K., Kobune, M., Sato, Y., Takayama, T., Matunaga, T., and Niitsu, Y. (2006). Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor α expression via activation of nuclear factor-κB. Gut 55, 1801-1808.
71. Schmitz, K.J., Wohlschlaeger, J., Lang, H., Sotiropoulos, G.C., Malago, M., Steveling, K., Reis, H., Cicinnati, V.R., Schmid, K.W., and Baba, H.A. (2008). Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J. Hepatol. 48, 83-90.
72. Schrager, J.A., Der Minassian, V., and Marsh, J.W. (2002). HIV Nef increases T cell ERK MAP kinase activity. J. Biol. Chem. 277, 6137-6142.
73. Sebolt-Leopold, J.S., Dudley, D.T., Herrera, R., Van Becelaere, K., Wiland, A., Gowan, R.C., Tecle, H., Barrett, S.D., Bridges, A., Przybranowski, S., et al. (1999). Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5, 810-816.
74. Shan, M., Klasse, P.J., Banerjee, K., Dey, A.K., Iyer, S.P., Dionisio, R., Charles, D., Campbell-Gardener, L., Olson, W.C., Sanders, R.W., and Moore, J.P. (2007). HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 3, e169.
75. Sprang, S.R. (1997). G proteins, effectors and GAPs: structure and mechanism. Curr. Opin. Struct. Biol. 7, 849-856.
76. Thompson, N. and Lyons, J. (2005). Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery. Curr. Opin. Pharmacol. 5, 350-356.
77. Tomkowicz, B., Lee, C., Ravyn, V., Cheung, R., Ptasznik, A., and Collman, R.G. (2006). The Src kinase Lyn is required for CCR5 signaling in response to MIP-1β and R5 HIV-1 gp120 in human macrophages. Blood 108, 1145-1150.
78. Toschi, E., Bacigalupo, I., Strippoli, R., Chiozzini, C., Cereseto, A., Falchi, M., Nappi, F., Sgadari, C., Barillari, G., Mainiero, F., and Ensoli, B. (2006). HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Mol. Biol. Cell 17, 1985-1994.
79. Tsutsumi, T., Suzuki, T., Moriya, K., Shintani, Y., Fujie, H., Miyoshi, H., Matsuura, Y., Koike, K., and Miyamura, T. (2003). Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 38, 820-828.
80. Wang, D., Boerner, S.A., Winkler, J.D., and LoRusso, P.M. (2007a). Clinical experience of MEK inhibitors in cancer therapy. Biochim. Biophys. Acta 1773, 1248-1255.
81. Wang, J.Y., Wilcoxen, K.M., Nomoto, K., and Wu, S. (2007b). Recent advances of MEK inhibitors and their clinical progress. Curr. Top. Med. Chem. 7, 1364-1378.
82. Wolff, T., Zielecki, F., Abt, M., Semmler, I., and Matthaei, M. (2008). Sabotage of antiviral signaling and effectors by influenza viruses. Biol. Chem. 389, 1299-1305.
83. Wong, J., Zhang, J., Si, X., Gao, G., and Luo, H. (2007). Inhibition of the extracellular signal-regulated kinase signaling pathway is correlated with proteasome inhibitor suppression of cox-sackievirus replication. Biochem. Biophys. Res. Commun. 358, 903-907.
84. Wu, R.F., Ma, Z., Myers, D.P., and Terada, L.S. (2007). HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J. Biol. Chem. 282, 37412-37419.
85. Wymann, M.P. and Schneiter, R. (2008). Lipid signalling in disease. Nat. Rev. Mol. Cell. Biol. 9, 162-176.
86. Yang, X. and Gabuzda, D. (1999). Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J. Virol. 73, 3460-3466.
87. Yang, X., Chen, Y., and Gabuzda, D. (1999). ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J. Biol. Chem. 274, 27981-27988.
88. Yao, Z.Q., Nguyen, D.T., Hiotellis, A.I., and Hahn, Y.S. (2001). Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167, 5264-5272.
89. Yoshizuka, N., Yoshizuka-Chadani, Y., Krishnan, V., and Zeichner, S.L. (2005). Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway. J. Virol. 79, 11366-11381.
90. Zampieri, C.A., Fortin, J.F., Nolan, G.P., and Nabel, G.J. (2007a). The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J. Virol. 81, 1230-1240.
91. Zampieri, C.A., Sullivan, N.J., and Nabel, G.J. (2007b). Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat. Immunol. 8, 1159-1164.
92. Zhao, L.J., Liu, H.Q., Cao, J., Feng, G.S., and Qi, Z.T. (2001). Activation of intracellular MAPK/ERK initiated by hepatitis C virus envelope protein E2 in HepG2 cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 33, 691-695.
93. Zhao, L.J., Wang, L., Ren, H., Cao, J., Li, L., Ke, J.S., and Qi, Z.T. (2005). Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Exp. Cell Res. 305, 23-32.
94. Zhao, L.J., Zhang, X.L., Zhao, P., Cao, J., Cao, M.M., Zhu, S.Y., Liu, H.Q., and Qi, Z.T. (2006). Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. J. Leukoc. Biol. 80, 424-432.
95. Zhao, L.J., Zhao, P., Chen, Q.L., Ren, H., Pan, W., and Qi, Z.T. (2007). Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection. Cell Prolif. 40, 508-521.